Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T R Pedersen

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
American Heart Journal|July 30, 1999
Statin trials and goals of cholesterol-lowering therapy after AMIT R Pedersen
The New England Journal of Medicine|October 24, 1985
Six-year follow-up of the Norwegian Multicenter Study on Timolol after Acute Myocardial InfarctionT R Pedersen
The American Journal of Cardiology|March 21, 2001
Pro and con: low-density lipoprotein cholesterol lowering is and will be the key to the future of lipid managementT R Pedersen
The American Journal of Cardiology|December 22, 1998
Coronary artery disease: the Scandinavian Simvastatin Survival Study experienceT R Pedersen
Circulation|June 1, 1983
The Norwegian Multicenter Study of Timolol after Myocardial InfarctionT R Pedersen
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1996
Primary prevention of cardiovascular disease: implications of lipid-lowering trialsT R Pedersen
European Heart Journal|November 20, 1998
Aggressive lipid-lowering therapy: a clinical imperativeT R Pedersen
The American Journal of Medicine|October 8, 1996
Review of cholesterol-lowering therapy: coronary angiographic and events trialsD Waters, T R Pedersen
The American Journal of Cardiology|September 28, 1995
Reducing the risk of coronary events: evidence from the Scandinavian Simvastatin Survival Study (4S)J Kjekshus, T R Pedersen
Cardiovascular Drugs and Therapy|April 1, 1990
Nisoldipine tablets once daily versus nifedipine capsules three times daily in patients with stable effort angina pectoris pretreated with atenololT R Pedersen, M Kantor
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
American Heart Journal|July 30, 1999
Statin trials and goals of cholesterol-lowering therapy after AMIT R Pedersen
The New England Journal of Medicine|October 24, 1985
Six-year follow-up of the Norwegian Multicenter Study on Timolol after Acute Myocardial InfarctionT R Pedersen
The American Journal of Cardiology|March 21, 2001
Pro and con: low-density lipoprotein cholesterol lowering is and will be the key to the future of lipid managementT R Pedersen
The American Journal of Cardiology|December 22, 1998
Coronary artery disease: the Scandinavian Simvastatin Survival Study experienceT R Pedersen
Circulation|June 1, 1983
The Norwegian Multicenter Study of Timolol after Myocardial InfarctionT R Pedersen
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1996
Primary prevention of cardiovascular disease: implications of lipid-lowering trialsT R Pedersen
European Heart Journal|November 20, 1998
Aggressive lipid-lowering therapy: a clinical imperativeT R Pedersen
The American Journal of Medicine|October 8, 1996
Review of cholesterol-lowering therapy: coronary angiographic and events trialsD Waters, T R Pedersen
The American Journal of Cardiology|September 28, 1995
Reducing the risk of coronary events: evidence from the Scandinavian Simvastatin Survival Study (4S)J Kjekshus, T R Pedersen
Cardiovascular Drugs and Therapy|April 1, 1990
Nisoldipine tablets once daily versus nifedipine capsules three times daily in patients with stable effort angina pectoris pretreated with atenololT R Pedersen, M Kantor
Pageof 5